Insights into the structure and substrate interactions of the P-glycoprotein multidrug transporter from spectroscopic studies

被引:91
作者
Sharom, FJ [1 ]
Liu, RH [1 ]
Romsicki, Y [1 ]
Lu, PH [1 ]
机构
[1] Univ Guelph, Guelph Waterloo Ctr Grad Work Chem, Dept Chem & Biochem, Guelph, ON N1G 2W1, Canada
来源
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES | 1999年 / 1461卷 / 02期
关键词
fluorescence spectroscopy; nucleotide binding; drug binding; drug transport; lipid bilayer; reconstitution;
D O I
10.1016/S0005-2736(99)00166-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The P-glycoprotein multidrug transporter is a 170-kDa efflux pump which exports a diverse group of natural products, chemotherapeutic drugs, and hydrophobic peptides across the plasma membrane, driven by ATP hydrolysis. The transporter has been proposed to interact with its drug substrates within the membrane environment; however, much remains to be learned about the nature and number of the drug binding site(s). The two nucleotide binding domains are responsible for ATP binding and hydrolysis, which is coupled to drug movement across the membrane. In recent years, P-glycoprotein has been purified and functionally reconstituted in amounts large enough to allow biophysical studies. The use of spectroscopic techniques has led to insights into both its secondary and tertiary structure, and its interaction with nucleotides and drugs. In this review, we will summarise what has been learned by application to purified P-glycoprotein of fluorescence spectroscopy, circular dichroism spectroscopy and infra-red spectroscopy. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:327 / 345
页数:19
相关论文
共 89 条
[41]  
Kim AE, 1998, J PHARMACOL EXP THER, V286, P1439
[42]   The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors [J].
Kim, RB ;
Fromm, MF ;
Wandel, C ;
Leake, B ;
Wood, AJJ ;
Roden, DM ;
Wilkinson, GR .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (02) :289-294
[43]  
KO YH, 1993, J BIOL CHEM, V268, P24330
[44]   Drugs, ionophoric peptides, and steroids as substrates of the yeast multidrug transporter Pdr5p [J].
Kolaczkowski, M ;
vanderRest, M ;
CybularzKolaczkowska, A ;
Soumillion, JP ;
Konings, WN ;
Goffeau, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (49) :31543-31548
[45]   HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter [J].
Lee, CGL ;
Gottesman, MM ;
Cardarelli, CO ;
Ramachandra, M ;
Jeang, KT ;
Ambudkar, SV ;
Pastan, I ;
Dey, S .
BIOCHEMISTRY, 1998, 37 (11) :3594-3601
[46]  
LELONG IH, 1991, MOL PHARMACOL, V40, P490
[47]   Fluorescence studies on the nucleotide binding domains of the P-glycoprotein multidrug transporter [J].
Liu, RH ;
Sharom, FJ .
BIOCHEMISTRY, 1997, 36 (10) :2836-2843
[48]   Proximity of the nucleotide binding domains of the P-glycoprotein multidrug transporter to the membrane surface: A resonance energy transfer study [J].
Liu, RH ;
Sharom, FJ .
BIOCHEMISTRY, 1998, 37 (18) :6503-6512
[49]   Site-directed fluorescence labeling of P-glycoprotein on cysteine residues in the nucleotide binding domains [J].
Liu, RH ;
Sharom, FJ .
BIOCHEMISTRY, 1996, 35 (36) :11865-11873
[50]   Drug-stimulated ATPase activity of human P-glycoprotein requires movement between transmembrane segments 6 and 12 [J].
Loo, TW ;
Clarke, DM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (34) :20986-20989